Open AccessSevera ipocalcemia conseguente all’assunzione orale di citrato in un paziente in emodialisi cronica
Author(s) -
Franco Bergesio,
Stefano Aterini,
S. Bandini,
Franco Bergesio,
Anna Maria Ciciani,
Lorenzo Aterini,
Francesca Calderini,
Fiamma Balboni
Publication year - 2021
Publication title -
giornale di clinica nefrologica e dialisi
Language(s) - English
Resource type - Journals
ISSN - 2705-0076
DOI - 10.33393/gcnd.2021.2322
Subject(s) - hypocalcaemia , medicine , discontinuation , dialysis , hemodialysis , adverse effect , kidney disease , end stage renal disease , intensive care medicine , calcium
We report a case of an 81-year-old man with end stage renal disease (ESRD) in chronic hemodialysis with severe hypocalcaemia secondary to the intake of a parapharmaceutical containing sodium and potassium citrate and in association with poor dialysis efficiency, due to malfunction of the vascular access, which promptly resolved after discontinuation of the supplement. The patient never showed signs or symptoms of hypocalcaemia. This case highlightens the importance of a correct pharmacological reconciliation in dialysis patients in order to avoid the onset of adverse events due to the uncontrolled intake of drugs or parapharmaceuticals.